半導體附屬引資32億人民幣 長飛光纖(06869.HK)持股攤薄至22.9%
長飛光纖光纜(06869.HK)公布,公司及A輪投資者建議向長飛先進半導體以現金出資合共32.44億人民幣。募集資金將用於研發及生產第三代半導體。
完成後,公司於長飛先進半導體股權將由目前30.0511%%攤薄至22.9008%,不再有權提名大多數董事會成員,因此將失去對董事會組成的控制權。同時,視作出售股權產生收益3,500萬至5,000萬人民幣。
長飛先進半導體擬通過債務融資及股權融資籌集合共約60億人民幣,建設年產能36萬片6英寸碳化矽晶片及6100萬件功率器件模組的第三代半導體外延、晶片製造及封裝生產線。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.